Prostatic Hypertrophy, Benign Completed Phase 3 Trials for Alfuzosin (DB00346)

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

IndicationStatusPhase
DBCOND0029457 (Prostatic Hypertrophy, Benign)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00029822Clinical Trial in Males With BPH (Enlarged Prostate)Prevention